IBM (IBM) Reiterated at Buy by Stifel After $2B Chips Act Distribution Announced
Tweet Send to a Friend
Stifel analyst David Grossman reiterated a Buy rating and $290.00 price target on IBM (NYSE: IBM).The analyst commented, "the US ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
